BlackRock Institutional Trust Company, N.A. - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 138 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 2.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Institutional Trust Company, N.A. ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2016$13,082,000
-40.7%
3,206,460
-7.8%
0.00%
-33.3%
Q3 2016$22,075,000
+35.3%
3,476,313
+14.8%
0.00%0.0%
Q2 2016$16,320,000
-31.4%
3,027,839
+6.5%
0.00%
-25.0%
Q1 2016$23,788,000
+3.7%
2,842,035
-2.1%
0.00%0.0%
Q4 2015$22,942,000
+4.4%
2,904,102
+12.5%
0.00%0.0%
Q3 2015$21,973,000
-23.5%
2,581,970
+11.2%
0.00%
-20.0%
Q2 2015$28,713,000
-0.1%
2,322,152
-4.0%
0.01%
+25.0%
Q1 2015$28,749,000
+38.3%
2,419,959
+31.6%
0.00%
+33.3%
Q4 2014$20,785,000
+110.1%
1,839,347
+63.3%
0.00%
+50.0%
Q3 2014$9,891,000
+12.2%
1,126,576
-6.8%
0.00%
+100.0%
Q2 2014$8,816,000
+43.5%
1,209,383
-0.8%
0.00%0.0%
Q1 2014$6,145,000
-3.3%
1,219,155
+2.3%
0.00%0.0%
Q4 2013$6,354,000
+35.9%
1,191,938
-3.4%
0.00%0.0%
Q3 2013$4,677,000
-48.8%
1,234,068
-9.0%
0.00%
-50.0%
Q2 2013$9,142,0001,356,4030.00%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders